{
    "organizations": [],
    "uuid": "1c0c829b3c7e977635209bbb8e77e83590637d35",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-chase-sun-pharmaceutical-r/brief-tianjin-chase-sun-pharmaceutical-receives-gmp-certificate-idUSL4N1PK1K4",
    "ord_in_thread": 0,
    "title": "BRIEF-Tianjin Chase Sun Pharmaceutical receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25(Reuters) - Tianjin Chase Sun Pharmaceutical Co Ltd\n* Says it received GMP certificate for small-volume injection\n* Says the valid period is until Jan. 7, 2023\nSource text in Chinese: goo.gl/1RNZcS\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-25T10:46:00.000+02:00",
    "crawled": "2018-01-25T13:06:48.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "tianjin",
        "chase",
        "sun",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "received",
        "gmp",
        "certificate",
        "injection",
        "say",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}